233 related articles for article (PubMed ID: 12574098)
21. Use of antihypertension agents for the suppression of arterial pulse pressure waveforms in patients with intracranial aneurysms.
Turner CL; Wilkinson IB; Kirkpatrick PJ
J Neurosurg; 2006 Apr; 104(4):531-6. PubMed ID: 16619656
[TBL] [Abstract][Full Text] [Related]
22. [The impact of nitrates and mono-therapy and nitrates combined with angiotensin converting enzyme inhibitors on left ventricular remodeling and exercise capacity in patients after acute myocardial infarction].
Maciejewicz J; Maziarz A; Celibała R; Wiśniewski M; Wiśniewska M
Przegl Lek; 2003; 60(2):80-4. PubMed ID: 12939852
[TBL] [Abstract][Full Text] [Related]
23. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
[TBL] [Abstract][Full Text] [Related]
24. Vasodilator therapy of hypertensive acute left ventricular failure: comparison of captopril-prazosin with hydralazine-isosorbide dinitrate.
Adigun AQ; Ajayi OE; Sofowora GG; Ajayi AA
Int J Cardiol; 1998 Nov; 67(1):81-6. PubMed ID: 9880204
[TBL] [Abstract][Full Text] [Related]
25. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
26. Single-dose effects of isosorbide mononitrate alone or in combination with losartan on central blood pressure.
Kaufman R; Nunes I; Bolognese JA; Miller DL; Salotti D; McCarthy JM; Smith WB; Herman GA; Feig PU
J Am Soc Hypertens; 2010; 4(6):311-8. PubMed ID: 21130977
[TBL] [Abstract][Full Text] [Related]
27. Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men.
Mahmud A; Hennessy M; Feely J
J Hum Hypertens; 2001 Oct; 15(10):707-13. PubMed ID: 11607801
[TBL] [Abstract][Full Text] [Related]
28. Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Eprosartan Study Group.
Gradman AH; Gray J; Maggiacomo F; Punzi H; White WB
Clin Ther; 1999 Mar; 21(3):442-53. PubMed ID: 10321414
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of eprosartan and captopril in left ventricular systolic dysfunction: relation of efficacy to myocardial viability].
Shalaev SV; Metlitskaia EV; Teffenberg DV; Shanaurina NV; Petrik ES; Volkova SIu
Kardiologiia; 2004; 44(1):10-3. PubMed ID: 15029143
[TBL] [Abstract][Full Text] [Related]
30. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
31. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.
Lancet; 1995 Mar; 345(8951):669-85. PubMed ID: 7661937
[TBL] [Abstract][Full Text] [Related]
32. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
[TBL] [Abstract][Full Text] [Related]
33. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Punzi HA; Punzi CF
J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
[TBL] [Abstract][Full Text] [Related]
34. Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension.
Oliver JJ; Hughes VE; Dear JW; Webb DJ
Hypertension; 2010 Jul; 56(1):62-7. PubMed ID: 20479335
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
[TBL] [Abstract][Full Text] [Related]
36. Effects of angiotensin-converting enzyme inhibitor alacepril in patients with stable effort angina during chronic isosorbide dinitrate treatment.
Murohara T; Tayama S; Tabuchi T; Sumida H; Honda T; Hayasaki K; Yasue H
Am J Cardiol; 1996 Jun; 77(14):1159-63. PubMed ID: 8651088
[TBL] [Abstract][Full Text] [Related]
37. [Effect of isosorbide mononitrate on hypotensive action of enalapril in patients with mild and moderate hypertension].
Przewłocka-Kosmala M
Pol Merkur Lekarski; 2002 Jul; 13(73):40-2. PubMed ID: 12362504
[TBL] [Abstract][Full Text] [Related]
38. The role of sustained release isosorbide mononitrate on corticosteroid-induced hypertension in healthy human subjects.
Williamson PM; Ong SL; Whitworth JA; Kelly JJ
J Hum Hypertens; 2015 Dec; 29(12):737-43. PubMed ID: 25810066
[TBL] [Abstract][Full Text] [Related]
39. Sustained-release isosorbide mononitrate as adjuvant treatment in isolated systolic hypertension in the elderly.
Abad Pérez D; García Polo I; Rodríguez Salvanés FJ; Bellisco Roncal S; Ibáñez Sanz P; Suárez Fernández C
J Hum Hypertens; 2022 Feb; 36(2):163-170. PubMed ID: 33850272
[TBL] [Abstract][Full Text] [Related]
40. Effects of 5-isosorbide mononitrate and propranolol on subclinical hepatic encephalopathy and renal function in patients with liver cirrhosis.
Silva G; Segovia R; Ponce R; Backhouse C; Palma M; Roblero JP; Abadal J; Quijada C; Troncoso M; Iturriaga H
Hepatogastroenterology; 2002; 49(47):1357-62. PubMed ID: 12239942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]